Standard

PHARMACOECONOMIC PERSPECTIVES ON THE USE OF INOTUZUMAB OZOGAMICIN IN THE TREATMENT OF RELAPSED OR REFRACTORY FORMS OF B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA. / Kolbin, A.; Vilum, I.; Balykina, Y.; Proskurin, M.

в: Value in Health, Том 22, 11.2019, стр. S501-S501.

Результаты исследований: Научные публикации в периодических изданияхтезисыРецензирование

Harvard

APA

Vancouver

Author

BibTeX

@article{91c26d73f0bc4667a8794100aa6a5fd9,
title = "PHARMACOECONOMIC PERSPECTIVES ON THE USE OF INOTUZUMAB OZOGAMICIN IN THE TREATMENT OF RELAPSED OR REFRACTORY FORMS OF B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA",
author = "A. Kolbin and I. Vilum and Y. Balykina and M. Proskurin",
year = "2019",
month = nov,
language = "Английский",
volume = "22",
pages = "S501--S501",
journal = "Value in Health",
issn = "1098-3015",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - PHARMACOECONOMIC PERSPECTIVES ON THE USE OF INOTUZUMAB OZOGAMICIN IN THE TREATMENT OF RELAPSED OR REFRACTORY FORMS OF B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

AU - Kolbin, A.

AU - Vilum, I.

AU - Balykina, Y.

AU - Proskurin, M.

PY - 2019/11

Y1 - 2019/11

M3 - тезисы

VL - 22

SP - S501-S501

JO - Value in Health

JF - Value in Health

SN - 1098-3015

ER -

ID: 50366131